+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Therapy of high malignant non hodgkin lymphoma stage i of low malignant non hodgkin lymphoma stages i and ii and centroblastic centrocytic lymphoma stages i iii



Therapy of high malignant non hodgkin lymphoma stage i of low malignant non hodgkin lymphoma stages i and ii and centroblastic centrocytic lymphoma stages i iii



Journal of Cancer Research & Clinical Oncology 111(SUPPL): S5




(PDF emailed within 1 workday: $29.90)

Accession: 029445030

Download citation: RISBibTeXText


Related references

Therapy of high malignant Non-Hodgkin-Lymphoma (NHL) stage I, of low malignant NHL stages I and II, and of centroblastic-centrocytic lymphoma stages IIII. Journal of Cancer Research and Clinical Oncology 111(1 Supplement): S5-0, 1986

Clinical aspects of malignant non-Hodgkin's-lymphomas with reference to Kiel classification: centrocytic lymphoma, centroblastic-centrocytic lymphoma, lymphoblastic lymphoma, immunoblastic lymphoma. Hamatologie und Bluttransfusion 18: 211-223, 1976

Immunophenotypes of malignant lymphoma centroblastic-centrocytic and malignant lymphoma centrocytic: an immunohistologic study indicating a derivation from different stages of B cell differentiation. Human Pathology 19(9): 1053-1059, 1988

Radiation treatment of centroblastic centrocytic non-Hodgkin-lymphoma in early stages First results of a German multicentre trial. Annals of Hematology 67(SUPPL ): A105, 1993

Primary gastrointestinal form of the Brill-Symmers disease. Low-grade malignant non-Hodgkin lymphoma of the centroblastic/centrocytic type. Medizinische Klinik 72(49): 2127-2131, 1977

Translocation (14; 18) and (8; 22) in three patients with acute leukemia/lymphoma following centrocytic/centroblastic non-Hodgkin's lymphoma. Annals of Hematology 63(5): 282-287, 1991

Centroblastic-centrocytic non-Hodgkin's lymphoma Stage I-III: Patterns of failure following radiotherapy. Strahlentherapie und Onkologie 177(11): 597-603, 2001

Sequential chemotherapy of malignant non-Hodgkin's lymphoma of high degree of malignancy in stages III and IV. Onkologie 5(5): 222-227, 1982

Favorable long-term outcome with mistletoe therapy in a patient with centroblastic-centrocytic non hodgkin lymphoma. Deutsche Medizinische Wochenschrift 125(31-32): 958-960, 2000

Favorable long-term outcome with mistletoe therapy in a patient with centroblastic-centrocytic non-Hodgkin lymphoma. Deutsche Medizinische Wochenschrift 124(47): 1414-1418, 1999

Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group. Journal of Clinical Oncology 16(1): 41-47, 1998

Malignant lymphoma. Advances in diagnosis and treatment. III. Practice of diagnosis (Standard therapy). 1. Standard therapy of malignant lymphoma (Hodgkin's disease and non-Hodgkin's lymphoma ). Nihon Naika Gakkai Zasshi 90(6): 997-1002, 2001

FDG-PET for the metabolic characterization of centroblastic-centrocytic non-Hodgkin lymphoma. Journal of Nuclear Medicine 40(5 SUPPL ): 214P, 1999

Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extended high-dose irradiation. Blood 104(9): 2675-2681, 2004

Polymerase chain reaction monitoring shows a high efficacy of clinical immunomagnetic purging in patients with centroblastic-centrocytic non-Hodgkin's lymphoma. Blood 80(10): 2688-2690, 1992